Polymethacrylate microparticles gel for topical drug delivery

Pharmaceutical Research

Volumn 27, Issue 10, 2010, Pages 2106-2118

  Labouta, Hagar Ibrahim ^a   El Khordagui, Labiba K ^a  

^a Alexandria University Faculty of Pharmacy   (Egypt)

Author keywords

microparticles gel; polymethacrylates; topical drug delivery; verapamil

Indexed keywords

EUDRAGIT; POLYMER; POLYMETHACRYLIC ACID; VERAPAMIL;

ADULT; ARTICLE; CONTROLLED RELEASE FORMULATION; CONTROLLED STUDY; DIFFERENTIAL SCANNING CALORIMETRY; DRUG DELIVERY SYSTEM; DRUG RELEASE; DRUG RETENTION; DRUG SOLUBILITY; EMULSION; FEMALE; GEL; HUMAN; HUMAN TISSUE; PARTICLE SIZE; PRIORITY JOURNAL; SCANNING ELECTRON MICROSCOPY; SKIN PERMEABILITY;

ACRYLIC RESINS; ADMINISTRATION, TOPICAL; ADULT; CALCIUM CHANNEL BLOCKERS; CALORIMETRY, DIFFERENTIAL SCANNING; DELAYED-ACTION PREPARATIONS; DRUG CARRIERS; FEMALE; GELS; HUMANS; MICROSCOPY, ELECTRON, SCANNING; MIDDLE AGED; PARTICLE SIZE; POLYMETHACRYLIC ACIDS; SKIN; SKIN ABSORPTION; SOLUBILITY; SURFACE PROPERTIES; VERAPAMIL;

EID: 77957340048     PISSN: 07248741     EISSN: 1573904X     Source Type: Journal    
DOI: 10.1007/s11095-010-0212-9     Document Type: Article

References (55)

1. M Li O Rouaud D Poncelet 2008 Microencapsulation by solvent evaporation: state of the art for process engineering approaches Int J Pharm 363 26 39 10.1016/j.ijpharm.2008.07.018 18706988 1:CAS:528:DC%2BD1cXhtFensr7L
2. NS Berchane FF Jebrail MJ Andrews 2010 Optimization of PLG microspheres for tailored drug release Int J Pharm 383 81 8 10.1016/j.ijpharm.2009.09.010 19748560 1:CAS:528:DC%2BD1MXhsVCksrvJ
3. YS Lee JP Lowe E Gilby S Perera SP Rigby 2010 The initial release of cisplatin from poly(lactide-co-glycolide) microspheres Int J Pharm 383 244 54 10.1016/j.ijpharm.2009.09.021 19766179 1:CAS:528:DC%2BD1MXhsVCksrzJ
4. W Wei GH Ma LY Wang J Wu ZG Su 2010 Hollow quaternized chitosan microspheres increase the therapeutic effect of orally administered insulin Acta Biomater 6 205 9 10.1016/j.actbio.2009.06.005 19505595 1:CAS:528: DC%2BC3cXotVSqsg%3D%3D
5. ML Kang CS Cho HS Yoo 2009 Application of chitosan microspheres for nasal delivery of vaccines Biotechnol Adv 27 857 65 10.1016/j.biotechadv.2009.06.007 19583998 1:CAS:528:DC%2BD1MXht1CqtbnE
6. M Patel SK Jain AK Yadav D Gogna GP Agrawal 2006 Preparation and characterization of oxybenzone-loaded gelatin microspheres for enhancement of sunscreening efficacy Drug Deliv 13 323 30 10.1080/10717540500398175 16877306 1:CAS:528:DC%2BD28XnvFyrs7g%3D (Pubitemid 44180012)
7. S Smith V Morhenn G Webster 2006 The characteristics and utility of solid phase porous microspheres: a review J Drugs Dermatol 5 969 74 17373146
8. GB Kasting VD Bhatt TJ Speaker 2008 Microencapsulation decreases the skin absorption of N, N-diethyl-m-toluamide (DEET) Toxicol In Vitro 22 548 52 10.1016/j.tiv.2007.11.003 18093794 1:CAS:528:DC%2BD1cXhsFygtLo%3D
9. Kadianand SS, Harikumar SL. Eudragit and its pharmaceutical significance. Roorkee. 2009;17.
10. J Lademann H Richter K Golz L Zastrow W Sterry A Patzelt 2008 Influence of microparticles on the homogeneity of distribution of topically applied substances Skin Pharmacol Physiol 21 274 82 10.1159/000148043 18663341 1:CAS:528:DC%2BD1cXhtV2jsb%2FP
11. Y Choi SY Kim SH Kim K-S Lee C Kim Y Byun 2001 Long-term delivery of all-trans-retinoic acid using biodegradable PLLA/PEG-PLLA blended microspheres Int J Pharm 215 67 81 10.1016/S0378-5173(00)00676-1 11250093 1:CAS:528:DC%2BD3MXhsleltb8%3D (Pubitemid 32206605)
12. A Haddadi R Aboofazeli M Erfan ES Farboud 2008 Topical delivery of urea encapsulated in biodegradable PLGA microparticles: O/W and W/O creams J Microencapsul 25 379 86 10.1080/02652040802000714 18465299 1:CAS:528: DC%2BD1cXptlSqurw%3D
13. D Singh S Saraf VK Dixit S Saraf 2008 Formulation optimization of gentamicin loaded Eudragit RS100 microspheres using factorial design study Biol Pharm Bull 31 662 7 10.1248/bpb.31.662 18379059 1:CAS:528:DC%2BD1cXmtlarsrk%3D (Pubitemid 351500505)
14. YA Gomaa LK El-Khordagui NA Boraei IA Darwish 2010 Chitosan microparticles incorporating a hydrophilic sunscreen agent Carbohydr Polym 81 234 42 10.1016/j.carbpol.2010.02.024 1:CAS:528:DC%2BC3cXlsFCisLo%3D
15. M Kilicarslanand T Baykara 2004 Effects of the permeability characteristics of different polymethacrylates on the pharmaceutical characteristics of verapamil hyhdrochloride-loaded microspheres J Microencapsul 21 175 89 10.1080/02652040310001637820 1:CAS:528:DC%2BD2cXhslCnt7s%3D (Pubitemid 38401097)
16. N Yüksel T Tinçer T Baykara 1996 Interaction between nicardipine hydrochloride and polymeric microspheres for a controlled release system Int J Pharm 140 145 54 10.1016/0378-5173(96)04560-7 (Pubitemid 26292761)
17. L Palamarasand K Kyriakis 2005 Calcium antagonists in dermatology: a review of the evidence and research-based studies Dermatol Online J 11 8
18. B Fallon 2008 'Off-label' drug use in sexual medicine treatment: Peyronie's disease Int J Impot Res 20 127 34 10.1038/sj.ijir.3901610 17851582 1:STN:280:DC%2BD1c7nsVektg%3D%3D (Pubitemid 351374328)
19. CD Helmke 2004 Current topical treatments in wound healing: part 1 IJPC 8 269
20. Easterling WJ. Noninvasive method for treating cellulite through transdermal delivery of calcium channel blocker agents and medicament for use in such method, United States, 2002.
21. F D'Andrea S Brongo G Ferraro A Baroni 2002 Prevention and treatment of keloids with intralesional verapamil Dermatology 204 60 2 10.1159/000051812 11834852 (Pubitemid 34136816)
22. IE Roseborough MA Grevious RC Lee 2004 Prevention and treatment of excessive dermal scarring J Natl Med Assoc 96 108 16 14746360
23. WP Fitch 3rd WJ Easterling RL Talbert MJ Bordovsky M Mosier 2007 Topical verapamil HCl, topical trifluoperazine, and topical magnesium sulfate for the treatment of Peyronie's disease-a placebo-controlled pilot study J Sex Med 4 477 84 10.1111/j.1743-6109.2006.00417.x 17367443 1:CAS:528:DC%2BD2sXltFSlu78%3D (Pubitemid 46394721)
24. Snider T. Verapamil gel found effective in Peyronie's disease. Urol Times.
25. P Ioulios M Charalampos T Efrossini 2003 The spectrum of cutaneous reactions associated with calcium antagonists: a review of the literature and the possible etiopathogenic mechanisms Dermatol Online J 9 6 14996379
26. British Pharmacopoeia, Stationary office, London, 2003.
27. Pharmacopoeia E. Council of Europe. France: Strasbourg codex; 2001.
28. HI Labouta LK el-Khordagui AM Molokhia GM Ghaly 2009 Multivariate modeling of encapsulation and release of an ionizable drug from polymer microspheres J Pharm Sci 98 4603 15 10.1002/jps.21753 19645004 1:CAS:528:DC%2BD1MXhtlCjs7fF
29. BB Horoz M Kilicarslan N Yuksel T Baykara 2004 Effect of different dispersing agents on the characteristics of Eudragit microspheres prepared by a solvent evaporation method J Microencapsul 21 191 202 10.1080/ 02652040310001637893 15198430 1:CAS:528:DC%2BD2cXhslCnt7Y%3D (Pubitemid 38401098)
30. SA Wissingand RH Muller 2002 Solid lipid nanoparticles as carrier for sunscreens: in vitro release and in vivo skin penetration J Control Release 81 225 33 10.1016/S0168-3659(02)00056-1 (Pubitemid 34607144)
31. GK Jain AK Sharma SS Agrawal 1996 Transdermal controlled administration of verapamil-enhancement of skin permeability Int J Pharm 130 169 77 10.1016/0378-5173(95)04222-9 1:CAS:528:DyaK28XjtFSlurs%3D
32. A Shahiwalaand A Misra 2002 Studies in topical application of niosomally entrapped Nimesulide J Pharm Pharm Sci 5 220 5
33. EH Nafea MA El-Massik LK El-Khordagui MK Marei NM Khalafallah 2007 Alendronate PLGA microspheres with high loading efficiency for dental applications J Microencapsul 24 525 38 10.1080/02652040701439807 17654173 1:CAS:528:DC%2BD2sXotVOjtLY%3D (Pubitemid 47180536)
34. BB Horoz M Klicarslan N Yuksel T Baykara 2006 Influence of aluminum tristearate and sucrose stearate as the dispersing agents on physical properties and release characteristics of eudragit RS microspheres AAPS PharmSciTech 7 E1 7 10.1208/pt070116 (Pubitemid 43338074)
35. H Shivakumar S Suresh B Desa 2006 Design and evaluation of controlled onset extended release multiparticulate systems for chronotherapeutic delivery of ketoprofen Indian J Pharm Sci 68 76 82 10.4103/0250-474X.22969 1:CAS:528:DC%2BD28XlsVCgtL4%3D
36. F Salaün E Devaux S Bourbigot P Rumeau 2010 Influence of the solvent on the microencapsulation of an hydrated salt Carbohydr Polym 79 964 74 10.1016/j.carbpol.2009.10.027 1:CAS:528:DC%2BC3cXnvFahuw%3D%3D
37. R Govindarajanand MS Nagarsenker 2004 Basic drug-enterosoluble polymer coevaporates: development of oral controlled release systems Drug Dev Ind Pharm 30 847 57 10.1081/DDC-200034572 1:CAS:528:DC%2BD2cXotVektL8%3D (Pubitemid 39362869)
38. E Esposito R Roncarati R Cortesi F Cervellati C Nastruzzi 2000 Production of Eudragit microparticles by spray-drying technique: influence of experimental parameters on morphological and dimensional characteristics Pharm Dev Technol 5 267 78 10.1081/PDT-100100541 10810756 1:CAS:528:DC%2BD3cXjtV2lsrc%3D (Pubitemid 30247107)
39. LS Wan PW Heng LW Chan 1994 Surfactant effects on alginate microspheres Int J Pharm 103 267 75 10.1016/0378-5173(94)90177-5 1:CAS:528:DyaK2cXhslegs7g%3D (Pubitemid 24073688)
40. S Freitas HP Merkle B Gander 2005 Microencapsulation by solvent extraction/evaporation: reviewing the state of the art of microsphere preparation process technology J Control Release 102 313 32 10.1016/j.jconrel. 2004.10.015 15653154 1:CAS:528:DC%2BD2MXktVCrtg%3D%3D
41. L Lewis R Boni CM Adeyeye 1998 Effect of emulsifier blend on the characteristics of sustained release diclofenac microspheres J Microencapsul 15 283 98 10.3109/02652049809006858 9608393 1:CAS:528:DyaK1cXivFOhtLg%3D
42. Zidan AS, Sammour OA, Hammad MA, Megrab NA, Hussain MD, Khan MA, et al. Formulation of anastrozole microparticles as biodegradable anticancer drug carriers. Acta Pharm. 7.
43. C-H Zheng J-Q Gao Y-P Zhang W-Q Liang 2004 A protein delivery system: biodegradable alginate-chitosan-poly(lactic-co-glycolic acid) composite microspheres Biochem Biophys Res Commun 323 1321 7 10.1016/j.bbrc.2004.09.007 15451441 1:CAS:528:DC%2BD2cXnvVyrt74%3D (Pubitemid 39296569)
44. AS Tatavarti KA Mehta LL Augsburger SW Hoag 2004 Influence of methacrylic and acrylic acid polymers on the release performance of weakly basic drugs from sustained release hydrophilic matrices J Pharm Sci 93 2319 31 10.1002/jps.20129 15295792 1:CAS:528:DC%2BD2cXnsVegu70%3D (Pubitemid 39129629)
45. J Siepmann H Kranz R Bodmeier NA Peppas 1999 HPMC-matrices for controlled drug delivery: a new model combining diffusion, swelling, and dissolution mechanisms and predicting the release kinetics Pharm Res 16 1748 56 10.1023/A:1018914301328 10571282 1:CAS:528:DyaK1MXnt1GgsLo%3D (Pubitemid 29530409)
46. M Ramirez-Camposand L Villafuerte-Robles 2004 Effect of formulation variables on verapamil hydrochloride release from hydrated HPMC matrices Rev Soc Quím Méx 48 326 31
47. MM Nounou LK El-Khordagui NA Khalafallah SA Khalil 2006 In vitro release of hydrophilic and hydrophobic drugs from liposomal dispersions and gels Acta Pharm 56 311 24 19831280 1:CAS:528:DC%2BD28XpvFahu78%3D
48. HS Barakat IA Darwish LK El-Khordagui NM Khalafallah 2009 Development of naftifine hydrochloride alcohol-free niosome gel Drug Dev Ind Pharm 35 631 7 10.1080/03639040802498864 18989805 1:CAS:528:DC%2BD1MXlvVCksr4%3D
49. J Akbuga 1989 Preparation and evaluation of controlled release furosemide microspheres by spherical crystallization Int J Pharm 53 99 105 10.1016/0378-5173(89)90233-0 1:CAS:528:DyaL1MXlt1Skurg%3D (Pubitemid 19198380)
50. P Costaand JM Sousa Lobo 2001 Modeling and comparison of dissolution profiles Eur J Pharm Sci 13 123 33 10.1016/S0928-0987(01)00095-1 (Pubitemid 32288781)
51. HS Shah K Tojo YW Chien 1992 Transdermal controlled delivery of verapamil: characterization of in vitro skin permeation Int J Pharm 86 167 73 10.1016/0378-5173(92)90194-7 1:CAS:528:DyaK3sXislersw%3D%3D
52. SN Tenjarla R Allen A Borazani 1994 Evaluation of verapamil hydrochloride permeation through human cadaver skin Drug Dev Ind Pharm 20 49 63 10.3109/03639049409047213 1:CAS:528:DyaK2cXhsVeqsLk%3D
53. Azarbayjani AF, Khu J, Chan Y, Chan S. Skin penetration retardants: levothyroxine-loaded polymeric microparticles and their potential for topical skin delivery, AAPS Annual Meeting and Exposition, AAPS, Atlanta, Georgia, 2008.
54. JB Alencastre MVLB Bentley FS Garcia M De Moragas JL Viladot JM Marchetti 2006 A study of the characteristics and in vitro permeation properties of CMC/chitosan microparticles as a skin delivery system for vitamin E Braz J Pharm Sci 42 69 76 1:CAS:528:DC%2BD28XnsVaht7w%3D
55. DD Verma S Verma G Blume A Fahr 2003 Liposomes increase skin penetration of entrapped and non-entrapped hydrophilic substances into human skin: a skin penetration and confocal laser scanning microscopy study Eur J Pharm Biopharm 55 271 7 10.1016/S0939-6411(03)00021-3 12754000 1:CAS:528:DC%2BD3sXjs1Gjt70%3D (Pubitemid 36561553)